Bosh sahifaI5X • FRA
Precigen Inc
1,29 €
31-yan, 23:00:17 (GMT+1) · EUR · FRA · Ogohlantirish
AksiyalarDE qimmatli qogʻozi
Yopilish kursi
1,21 €
Kunlik diapazon
1,29 € - 1,29 €
Yillik diapazon
0,63 € - 1,80 €
Bozor kapitalizatsiyasi
395,37 mln USD
Oʻrtacha hajm
1,88 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD)sen, 2024Y/Y qiyosi
Daromad
953,00 ming-30,89%
Joriy xarajat
21,21 mln2,05%
Sof foyda
-23,98 mln-21,13%
Sof foyda marjasi
-2,52 ming-75,28%
Har bir ulushga tushum
-0,09-12,50%
EBITDA
-20,59 mln-6,75%
Amaldagi soliq stavkasi
-0,05%
Jami aktivlari
Jami passivlari
(USD)sen, 2024Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
28,63 mln-61,18%
Jami aktivlari
83,47 mln-56,22%
Jami passivlari
28,10 mln-34,67%
Umumiy kapital
55,38 mln
Tarqatilgan aksiyalar
292,87 mln
Narxi/balansdagi bahosi
6,37
Aktivlardan daromad
-67,87%
Kapitaldan daromad
-96,09%
Naqd pulning sof oʻzgarishi
(USD)sen, 2024Y/Y qiyosi
Sof foyda
-23,98 mln-21,13%
Operatsiyalardan naqd pul
-22,73 mln-33,66%
Sarmoyadan naqd pul
5,65 mln-46,29%
Moliyadan naqd pul
32,13 mln
Naqd pulning sof oʻzgarishi
15,12 mln328,46%
Boʻsh pul
-14,67 mln-61,55%
Haqida
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Tashkil etilgan
21-may, 1998
Xodimlar soni
202
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu